Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Evaluating Fumagillin and Antiprotozoals for Soft Tunic Synd
2026-04-22
This study systematically assessed the efficacy of 20 antiprotozoal compounds, including Fumagillin, against Azumiobodo hoyamushi—the causative agent of soft tunic syndrome in Halocynthia roretzi. The findings inform targeted disinfection strategies for aquaculture and highlight Fumagillin’s moderate in vitro potency against this protozoan.
-
2X HyperFusion High-Fidelity Master Mix: Precision in Immuno
2026-04-22
Explore how the 2X HyperFusion High-Fidelity Master Mix enables ultra-accurate DNA amplification for immunogenomics and advanced cloning. Discover unique protocol insights, mechanistic depth, and evidence-based assay guidance that set this resource apart.
-
Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Robust
2026-04-21
Sulfo-Cy3 NHS ester streamlines protein and peptide labeling with unmatched water solubility, enabling high-fidelity fluorescent conjugation even for low-solubility targets. Its advanced chemistry reduces quenching and enhances reproducibility, making it an essential tool for demanding cell biology and vascular research workflows.
-
Technical Guidance for Angiotensin I/II (1-5) in RAS Workflo
2026-04-21
Angiotensin I/II (1-5) provides a standardized Asp-Arg-Val-Tyr-Ile peptide fragment for controlled modeling of blood pressure regulation and aldosterone signaling within the renin-angiotensin system. It should be used strictly in cardiovascular and renal research workflows focused on peptide hormone vasoconstriction or angiotensin signaling, and avoided in unrelated peptide or signaling studies due to its specific solubility and mechanistic scope.
-
HyperFluor 488 Goat Anti-Human IgG Antibody: Workflow Powerh
2026-04-20
HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody transforms detection of human immunoglobulins across immunofluorescence, Western blotting, and flow cytometry. APExBIO’s affinity-purified, Alexa Fluor 488-conjugated reagent delivers unmatched sensitivity, low background, and protocol flexibility for advanced biomedical research.
-
HyperScribe T7 High Yield Cy3 RNA Labeling Kit: High-Sensiti
2026-04-20
The HyperScribe T7 High Yield Cy3 RNA Labeling Kit offers a reliable, tunable workflow for generating fluorescent RNA probes suited for in situ hybridization and Northern blotting. Its robust performance and customization options address common laboratory challenges in probe yield, sensitivity, and reproducibility.
-
MG-262 (Z-Leu-Leu-Leu-B(OH)2): Integrative Insights into Pro
2026-04-19
Explore how MG-262 (Z-Leu-Leu-Leu-B(OH)2) advances proteasome inhibition research by connecting molecular action to real-time regulation of apoptosis and cell signaling. This article uniquely bridges mechanistic depth and practical protocol guidance for advanced life science workflows.
-
Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S
2026-04-18
This study introduces a patient-specific gastric cancer assembloid model integrating matched tumor organoids and stromal cell subpopulations, enabling a more physiologically relevant platform for preclinical drug testing. The findings highlight the importance of tumor microenvironment complexity in modulating drug response and resistance, providing valuable insights for personalized cancer chemotherapy research.
-
Vemurafenib (PLX4032): Optimizing Melanoma Research Workflow
2026-04-17
Vemurafenib (PLX4032) delivers robust and selective inhibition of oncogenic BRAF V600E, making it a gold-standard tool for melanoma proliferation and resistance studies. This guide demystifies its integration into experimental workflows, highlights advanced assay strategies, and offers troubleshooting insights anchored in the latest multi-omics research.
-
GRA12: A Conserved Virulence Factor in Toxoplasma gondii Acr
2026-04-16
A recent in vivo CRISPR screening study identifies GRA12 as a key secreted virulence factor required for Toxoplasma gondii infection across parasite strains and diverse mouse subspecies. This work advances our understanding of host-pathogen interactions and provides a foundation for broad-spectrum anti-parasitic strategies.
-
Applied Use of Cy3-dCTP in Direct Enzymatic DNA Labeling
2026-04-15
Cy3-dCTP (Cyanine 3-deoxycytidine triphosphate) empowers researchers with robust, high-efficiency fluorescent labeling in DNA and cDNA workflows. This article translates bench research and recent innovations into actionable guidance—optimizing PCR, Nick Translation, and advanced probe labeling for maximum signal and reproducibility.
-
Heparin Sodium: Glycosaminoglycan Anticoagulant in Modern Re
2026-04-14
Heparin sodium is a gold-standard glycosaminoglycan anticoagulant, enabling precise control over coagulation assays and translational thrombosis models. Explore advanced workflow adaptations, troubleshooting, and cutting-edge delivery strategies informed by both primary research and validated protocols.
-
Decitabine (5-Aza-2'-deoxycytidine) in Cancer Epigenetics: A
2026-04-13
Decitabine (5-Aza-2'-deoxycytidine) enables precision gene reactivation for hematopoietic and solid tumor research, with proven DNA methyltransferase inhibition. Here, we outline experimental best practices, troubleshooting, and advanced applications, linking protocol design directly to translational impact.
-
CX-5461: Applied RNA Polymerase I Inhibitor Workflows in Can
2026-04-13
CX-5461 is redefining cancer research by enabling precise, selective inhibition of ribosomal RNA synthesis in solid tumor models. This article details advanced workflows, troubleshooting strategies, and key innovations based on the latest mechanistic insights, positioning CX-5461 as a benchmark RNA polymerase I inhibitor for translational studies.
-
Puerarin Drives Osteogenesis in Dental Follicle Cells via Ni
2026-04-12
This study demonstrates that puerarin enhances the osteogenic differentiation of rat dental follicle cells by activating the nitric oxide pathway. The reversal of these effects by the NOS inhibitor L-NMMA acetate underscores the centrality of nitric oxide signaling in dental tissue regeneration strategies.